12AE
NMR structure and free-energy simulations for rational design of myotonic dystrophy RNA inhibitors
This is a non-PDB format compatible entry.
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | RNA (5'-R(*GP*AP*CP*AP*GP*CP*UP*GP*CP*UP*GP*UP*C)-3') | polymer | 13 | 4133.5 | 2 | Homo sapiens | ||
| 2 | C (B) | 2-(dimethylamino)ethyl {(5P)-1-{[2-(dimethylamino)ethyl]amino}-5-[5-(4-methylpiperazin-1-yl)pyridin-3-yl]isoquinolin-3-yl}carbamate | non-polymer | 520.7 | 1 | Chemie (A1DA4) |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 8267.0 | |
| Non-Polymers* | Number of molecules | 1 |
| Total formula weight | 520.7 | |
| All* | Total formula weight | 8787.7 |






